1% SPL7013 Gel

DRUG5 trials

Sponsors

Starpharma Pty Ltd

Conditions

Bacterial VaginosisRecurrent Bacterial Vaginosis (BV)

Phase 2

Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)

CompletedNCT01437722

Starpharma Pty LtdRecurrent Bacterial Vaginosis (BV)

Start: 2011-08-31Updated: 2013-11-20

Phase 3

A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis

CompletedNCT01577238

Starpharma Pty LtdBacterial Vaginosis

Start: 2012-03-28End: 2012-07-20Updated: 2019-07-17

A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis

CompletedNCT01577537

Starpharma Pty LtdBacterial Vaginosis

Start: 2012-04-17End: 2012-10-05Updated: 2019-07-17

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

CompletedNCT02236156

Starpharma Pty LtdBacterial Vaginosis

Start: 2014-10-03End: 2016-10-04Updated: 2018-06-25

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

CompletedNCT02237950

Starpharma Pty LtdBacterial Vaginosis

Start: 2014-10-13End: 2017-02-22Updated: 2019-07-22